Panacos Competitors
| PANC Stock | USD 0.0001 0.00 0.00% |
Panacos Pharmaceuticals vs Inyx Correlation
No risk reduction
The correlation between Panacos Pharmaceuticals and IYXI is 1.0 (i.e., No risk reduction) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Panacos Pharmaceuticals and IYXI in the same portfolio, assuming nothing else is changed.
Panacos Pharmaceuticals Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Panacos Pharmaceuticals and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Panacos and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Panacos Pharmaceuticals does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Panacos Stock performing well and Panacos Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Panacos Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ARNI | 2.98 | 1.30 | 0.00 | 0.60 | 0.00 | 0.00 | 100.00 | |||
| ONPH | 15.11 | 4.95 | 0.16 | 1.77 | 12.71 | 37.50 | 200.00 | |||
| BTTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TLOG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CALA | 22.99 | 6.48 | 0.09 | (0.81) | 20.97 | 100.00 | 280.00 | |||
| WUHN | 15.60 | 6.25 | 0.00 | (7.18) | 0.00 | 0.00 | 300.00 | |||
| IVBT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| KLDO | 146.28 | 74.38 | 0.00 | (3.55) | 0.00 | 0.00 | 4,998 | |||
| BXRXQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| IYXI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cross Equities Net Income Analysis
Compare Panacos Pharmaceuticals and related stocks such as Arno Therapeutics, Oncology Pharma, and Better Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IYXI | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (31 M) | (27.9 M) | (29.3 M) |
Panacos Pharmaceuticals and related stocks such as Arno Therapeutics, Oncology Pharma, and Better Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Panacos Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Panacos Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Panacos Pharmaceuticals Competitive Analysis
The better you understand Panacos Pharmaceuticals competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Panacos Pharmaceuticals' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Panacos Pharmaceuticals' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Panacos Pharmaceuticals Competition Performance Charts
Five steps to successful analysis of Panacos Pharmaceuticals Competition
Panacos Pharmaceuticals' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Panacos Pharmaceuticals in relation to its competition. Panacos Pharmaceuticals' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Panacos Pharmaceuticals in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Panacos Pharmaceuticals' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Panacos Pharmaceuticals, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Panacos Pharmaceuticals position
In addition to having Panacos Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Equity ETFs Thematic Idea Now
Broad Equity ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 548 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Panacos Pharmaceuticals Correlation with its peers. For information on how to trade Panacos Stock refer to our How to Trade Panacos Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Will Biotechnology sector continue expanding? Could Panacos diversify its offerings? Factors like these will boost the valuation of Panacos Pharmaceuticals. Anticipated expansion of Panacos directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Panacos Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.01) | Revenue Per Share | Quarterly Revenue Growth (0.20) | Return On Assets | Return On Equity |
Understanding Panacos Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Panacos's accounting equity. The concept of intrinsic value - what Panacos Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Panacos Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Panacos Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Panacos Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Panacos Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.